3i to offer venture capital funds to Eastern tigers with an eye on growth
This article was originally published in Clinica
The British and European investment house, 3i, has opened an office in Singapore. The venture capital organisation, which has been active in the medical technology field, with funding for start-ups and management buyouts, plans to target the ASEAN 5 group of Far Eastern countries.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.